Varying Virus-Specific Antibodies in Recently Recovered COVID-19 Patients
Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal…
Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal…
Bat-virus adaptation may explain species spillover, researchers say. A University of Saskatchewan (USask) research team has uncovered how bats can carry the Middle East respiratory…
Infection researchers from the German Primate Center identify starting points for vaccine development and therapy. The SARS coronavirus 2 (SARS-CoV-2) infects lung cells and is…
AAVCOVID technology is unique in the vaccine field in its ability to scale and adapt rapidly. Massachusetts Eye and Ear and Massachusetts General Hospital (MGH),…
Initial step towards developing fully human antibody therapeutics and diagnostics for COVID-19. Researchers at Utrecht University, Erasmus Medical Center, and Harbour BioMed (HBM) today reported…
Inflammatory immune response can cause T cells to become depleted, affecting patient outcomes in coronavirus cases and leaving them prone to secondary infection. Cytokine storms…
In an unprecedented effort, hundreds of thousands of researchers and clinicians worldwide are locked in a race against time to develop cures, vaccines, and better…
Researchers have discovered a promising new strategy for combating malaria, a mosquito-borne parasite that claims nearly a half-million lives each year. For a study reported…
A Scripps Research study reveals a likely site of vulnerability on the SARS-CoV-2 virus. An antibody recovered from a survivor of the SARS epidemic in…
Engineered virus that’s successful in mice may hold promise for COVID-19 vaccine. No vaccines exist that protect people against infections by coronaviruses, including SARS-CoV-2, which…
Early preclinical tests in lab models are encouraging. Infectious disease scientists report early development of a potential universal vaccine for Ebola viruses that preclinical tests…
You might have heard that COVID-19 vaccine trials are underway in Seattle. What exactly is being tested? How much longer will these tests take? And…
Researchers at the University of Iowa and the University of Georgia have developed a vaccine that fully protects mice against a lethal dose of MERS,…
University of Pittsburgh School of Medicine scientists today announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice,…
Universal Novel Nanoparticle Flu Vaccine Protects Against 6 Influenza Viruses in Mice A novel nanoparticle vaccine that combines two major influenza proteins is effective in…
Researchers produced a detailed picture of the part of SARS-CoV-2—the novel coronavirus that causes COVID-19—that allows it to infect human cells. The study points to…
A team of scientists at the Hong Kong University of Science and Technology (HKUST) has recently made an important discovery in identifying a set of…
Experts are troubled by the apparent lack of informed consent in a pilot study of the vaccine. A large scale malaria vaccine study led by…